During the projected period, the global submucosal lifting agent market is expected to grow at a CAGR of 6.9%. The market value is projected to increase from US$ 114.2 million in 2023 to US$ 222.6 million by 2033. The global market was valued at US$ 106.9 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 6.8% in 2023.
Market Outlook-
Key Market Attributes
| Market Size, 2022 | US$ 106.9 Million |
|---|---|
| Market Size, 2023 | US$ 114.2 Million |
| Market Size, 2033 | US$ 222.6 Million |
| Value CAGR (2023 to 2033) | 6.9% |
The market for submucosal lifting agents includes specific medical goods required for endoscopic procedures. These substances establish a safe separation between the mucosal and muscle layers of the gastrointestinal tract. This allows for more exact vision and less invasive treatment of diseases such as gastrointestinal bleeding, tumors, and polyps.
The rising prevalence of gastrointestinal illnesses, technical developments in endoscopy and increased knowledge about early detection, needs are all driving market expansion. Submucosal lifting agents play an important role in supporting successful and safe treatments, adding to the growth of the market as healthcare infrastructure expands and innovation continues.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global submucosal lifting agent market recorded a historic CAGR of 6.4% in the last 5 years from 2017 to 2022. The market value for the submucosal lifting agent market was around 30.8% of the overall US$ 347.0 million of the global endoscopic submucosal dissection market.
Semi Annual Market Update
| Particular | Value CAGR |
|---|---|
| H1 | 6.00% (2022 to 2032) |
| H2 | 7.93% (2022 to 2032) |
| H1 | 6.30% (2023 to 2033) |
| H2 | 7.51% (2023 to 2033) |
The increasing demand for minimally invasive surgical procedures and devices is driving the expansion of the submucosal lifting agent market. By providing less traumatic alternatives to standard surgical approaches, minimally invasive techniques have changed the medical world. Smaller incisions, less tissue damage, faster recovery times, and less postoperative pain for patients are all benefits of these operations.
Submucosal injection fluids are critical in improving the efficacy of minimally invasive endoscopic treatments. These agents improve visualization and access for healthcare workers during treatments such as polypectomies, resections, and lesion removal by generating a regulated gap between tissue layers. The use of submucosal lifting agents improves precision and lowers the likelihood of problems.
The submucosal lifting agent market is expected to develop as the demand for minimally invasive procedures rises due to patient preferences for faster recovery and better outcomes. By establishing ideal procedural circumstances, these agents support the goals of minimally invasive operations. Also, advances in the formulations and applications of submucosal lifting agents fit with the ongoing evolution of minimally invasive surgical methods.
In essence, the interaction between minimally invasive surgical devices with submucosal lifting agents creates a positive feedback loop, pushing the expansion of both sectors as they meet the growing demand for improved, patient-friendly medical techniques.
The rising prevalence of gastrointestinal problems like upper gastrointestinal bleeding, lower gastrointestinal bleeding, angiodysplasia, esophageal varices and peptic ulcer disease is a key factor driving the submucosal lifting agent market. As the prevalence of disorders such as gastrointestinal bleeding, polyps, and tumors rises, so does the demand for endoscopic operations that require submucosal lifting agents.
These chemicals form a barrier between tissue layers, allowing for better imaging and treatment. The growing prevalence of gastrointestinal illnesses emphasizes the significance of precise diagnosis and minimally invasive therapies, which supports the use of submucosal lifting agents. The emphasis on early identification and treatment by healthcare professionals amplifies the importance of these agents, positioning the market for growth as they play a crucial role in enhancing procedure results and patient care.
Principal Consultant
Due to high costs and a scarcity of trained practitioners, the submucosal lifting agent industry faces growth limits. These agent’s development and production costs can raise procedure prices, limiting availability for patients and healthcare facilities.
Likewise, specialized training is essential for practitioners to execute endoscopic procedures with these agents competently, but a dearth of appropriately qualified experts impedes widespread implementation. These constraints hamper market expansion by discouraging potential users from adopting the technology and preventing the incorporation of submucosal lifting agents into ordinary medical practices. Addressing these problems through cost-effective solutions and thorough training programs is critical to realizing this market's full growth potential.
| Country | Value CAGR |
|---|---|
| United States | 6.8% |
| Germany | 7.9% |
| United Kingdom | 6.3% |
| Japan | 6.0% |
| China | 7.2% |
| India | 10.0% |
The United States dominates the global market with 38.0% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period. The increased prevalence of gastrointestinal illnesses in the United States, especially colorectal cancer, drives the demand for submucosal lifting agents. These medicines are required for safer and more successful tumor resections and interventions during endoscopic operations.
As the incidence of colorectal cancer rises, so does the demand for precise diagnoses and least invasive therapies. Submucosal lifting agents make these surgeries easier and improve patient outcomes. The rising prevalence of gastrointestinal disorders emphasizes the significance of modern medical instruments, positioning the submucosal lifting agent market in the United States for growth.
Germany held about 6.7% share of the global market in 2022 and is projected to increase during the forecast period. Germany presents a leading market for submucosal lifting agents due to the high demand for advanced endoscopic procedures like endoscopic submucosal dissection (ESD). While Germany achieves impressive en bloc resection rates with ESD, curative resection rates remain moderate.
ESD necessitates expertise and varies based on case volume at different centers. The establishment of a multicenter registry highlights the nation's commitment to evaluating and enhancing ESD's technical success, curative rates, long-term outcomes, and economic viability. With limited European ESD data, Germany's focus on quality improvement in this domain makes it a promising market for effective submucosal lifting agents.
United Kingdom held 6.1% of the global market share in 2022. The submucosal lifting agent market is thriving in the UK due to the rising adoption of endoscopic submucosal dissection (ESD) for gastrointestinal high-grade intramucosal neoplasia and superficially invasive cancer. ESD's en bloc resection offers improved completeness of excision assessment and a lower risk of recurrence for benign lesions.
While piecemeal endoscopic mucosal resection (pEMR) remains favored by some, the benefits of ESD often outweigh drawbacks. The surge in the submucosal lifting agent market is attributed to the growing recognition of ESD's advantages and a shift towards incorporating this advanced technique into local and regional practices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Growth Outlook by Key Ingredients
| Ingredients | Value CAGR |
|---|---|
| Poloxamer 188 and Polyoxyl-15-hydroxystearate | 4.5% |
| Gellan Gum and Polysaccharide | 5.0% |
| Sodium Hyaluronate | 7.5% |
| Cellulose | 6.6% |
| Absorbable Starch Polymers | 7.8% |
| Poloxamers | 9.0% |
Sodium hyaluronate within the ingredient segment hold a revenue share of 28.4% in 2022, and the same trend is being followed over the forecasted period. Sodium hyaluronate is extensively used in the submucosal lifting agent market. As a naturally occurring glycosaminoglycan, it plays a pivotal role in wound healing, inflammation, and development. Its viscoelastic properties make it a prime choice in ophthalmic applications, protecting the corneal endothelium and maintaining anterior chamber depth during intraocular surgery.
Recent animal experiments reveal its potential in promoting corneal epithelial wound healing by stimulating cell migration, adhesion, and proliferation. Acting as a ligand for CD44, sodium hyaluronate's involvement in cell interactions and migration during re-epithelialization underscores its significance in the submucosal lifting agent market.
Market Growth Outlook by Key Applications
| Applications | Value CAGR |
|---|---|
| Polyps | 5.6% |
| Adenomas | 8.4% |
| Early-stage Cancers | 7.4% |
| Gastrointestinal Mucosal Lesions | 8.7% |
| Others | 5.1% |
Early-stage cancers held a market share of 32.7% in 2022. In the Submucosal Lifting Agent Market, a dominant application is the management of early-stage cancers within the gastrointestinal tract. Submucosal injection of lifting agent’s aids in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), techniques used for excising neoplasms confined to the mucosa or submucosa. This technique cushions polyps, adenomas, and early-stage cancers, enabling effective excision.
Synthetic agents like Eleview® and ORISE® have gained popularity due to extended submucosal fluid maintenance, reducing procedure times. ORISE® notably triggers a foreign body-type giant cell reaction, known as 'lifting agent granuloma.' These advancements underscore submucosal lifting agents' role in minimally invasive, effective early-stage cancer removal within the gastrointestinal tract.
Market Growth Outlook by Key End Users
| End Users | Value CAGR |
|---|---|
| Hospitals | 6.7% |
| Specialty Clinics | 6.2% |
| Surgical Centers | 7.9% |
| Others | 7.4% |
Hospitals held a market share of 37.0% in 2022. Given their role as key locations for surgical procedures, hospitals dominate the end-user segment of the submucosal lifting agent market. The regulated environment, the availability of experienced medical professionals, and the necessity for sophisticated surgical equipment drive the need for submucosal lifting agents. The fact that hospitals have a large caseload and a focus on patient outcomes solidifies their position as the major users of these novel surgical instruments.
Leading submucosal lifting agent manufacturers prioritize strategic collaborations as they attempt to develop new product lines and increase their global consumer base.
Similarly, recent developments related to companies in the submucosal lifting agent market have been tracked by the team at Future Market Insights, which are available in the full report.
Related Market Growth Outlook Scenario
| Particulars | Value CAGR |
|---|---|
| Gastroesophageal Reflux Disease (GERD) Devices Market | 4.0% |
| Gastroesophageal Junction Adenocarcinoma Therapeutics Market | 18.0% |
| Gastrointestinal Stromal Tumor (GIST) Therapeutics Market | 6.0% |
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East and Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and Northern Africa |
| Key Market Segments Covered | Ingredient, Application, End User and Region |
| Key Companies Profiled | Laborie; STERIS; Olympus America; Medtronic; Boston Scientific Corporation; Omnimed Ltd™; COSMO PHARMACEUTICALS; Micro-Tech Endoscopy; Ovesco Endoscopy AG |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is currently valued at around US$ 106.9 million in 2022.
The global estimate for 2023 is around US$ 114.2 million.
The global market is set to reach a valuation of around US$ 222.6 million by 2033.
Sales of the market are set to witness growth at a CAGR of 6.9% between 2023 and 2033.
Demand for the global market increased at a 6.4% CAGR from 2017 to 2022.
The United States, Germany, United Kingdom, Japan and Australia account for most demand within the market, currently holding around 59.5% market share.
The United States accounts for around 38.0% share of the global market in 2022.
The Germany market held a share of about 20.4% in the European market in 2022.
United Kingdom accounts for around 6.1% share of the global market in 2022.
Early-stage cancers segment held 32.7% share of the global market in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption/Usage Analysis
4.2. Products USP/ Features Analysis
4.3. Regulatory Approvals and Guidelines
4.4. Growing Gastrointestinal Disorders
4.5. Clinical Applications of Imaging Techniques in Diagnosis
4.6. Regulatory Landscape
4.6.1. Regulatory Frameworks in United States
4.6.2. Regulatory Frameworks in Europe
4.6.3. Regulatory Frameworks in India
4.6.4. Regulatory Frameworks in Australia
4.7. Porter’s Analysis
4.8. PESTLE Analysis
4.9. Value Chain Analysis
4.10. Unmet Needs
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure
5.1.2. Global Life Expectancy Market Outlook
5.1.3. Research and Development funding by Region
5.1.4. Global Diagnostic Ultrasound Market Overview – Parent Market Analysis
5.2. Forecast Factors - Relevance and Impact
5.2.1. Increasing Endoscopic Procedures
5.2.2. Rising Gastrointestinal Disorders
5.2.3. Advancements in Endoscopic Techniques
5.2.4. Growing Aging Population
5.2.5. Rise in Outpatient Procedures
5.2.6. Prevalence of Obesity-related Disorders
5.2.7. Increasing Healthcare Expenditure
5.2.8. Advancements in Material Science
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2017 to 2022
6.2. Current and Future Market Volume (Units) Analysis and Forecast Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
7.1. Regional Pricing Analysis
7.2. Pricing Break-up
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Size (US$ Million) Analysis and Forecast Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Ingredient
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Ingredient, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Ingredient, 2023 to 2033
9.3.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
9.3.2. Gellan gum and Polysaccharide
9.3.3. Sodium hyaluronate
9.3.4. Cellulose
9.3.5. Absorbable starch polymers
9.3.6. Poloxamers
9.4. Market Attractiveness Analysis By Ingredient
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
10.3.1. Polyps
10.3.2. Adenomas
10.3.3. Early-stage cancers
10.3.4. Gastrointestinal mucosal lesions
10.3.5. Others
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Surgical Centers
11.3.4. Others
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. United States
13.3.1.2. Canada
13.3.2. By Ingredient
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis By Region
13.4.1. By Country
13.4.2. By Ingredient
13.4.3. By Application
13.4.4. By End User
13.5. Market trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis and Forecast
13.8.1. United States Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Ingredient
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. Canada Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Ingredient
13.8.2.2.2. By Application
13.8.2.2.3. By End User
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Ingredient
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis By Region
14.4.1. By Country
14.4.2. By Ingredient
14.4.3. By Application
14.4.4. By End User
14.5. Market trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis and Forecast
14.8.1. Brazil Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Ingredient
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Mexico Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Ingredient
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Ingredient
14.8.3.2.2. By Application
14.8.3.2.3. By End User
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. United Kingdom
15.3.1.2. Germany
15.3.1.3. Italy
15.3.1.4. France
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Rest of Europe
15.3.2. By Ingredient
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis By Region
15.4.1. By Country
15.4.2. By Ingredient
15.4.3. By Application
15.4.4. By End User
15.5. Market trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis and Forecast
15.8.1. United Kingdom Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Ingredient
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Germany Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Ingredient
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Italy Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Ingredient
15.8.3.2.2. By Application
15.8.3.2.3. By End User
15.8.4. France Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Ingredient
15.8.4.2.2. By Application
15.8.4.2.3. By End User
15.8.5. Spain Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Ingredient
15.8.5.2.2. By Application
15.8.5.2.3. By End User
15.8.6. Russia Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Ingredient
15.8.6.2.2. By Application
15.8.6.2.3. By End User
15.8.7. BENELUX Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Ingredient
15.8.7.2.2. By Application
15.8.7.2.3. By End User
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Thailand
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Ingredient
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis By Region
16.4.1. By Country
16.4.2. By Ingredient
16.4.3. By Application
16.4.4. By End User
16.5. Market trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis and Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Ingredient
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Ingredient
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. Thailand Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Ingredient
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. Malaysia Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Ingredient
16.8.4.2.2. By Application
16.8.4.2.3. By End User
17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Ingredient
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis By Region
17.4.1. By Country
17.4.2. By Ingredient
17.4.3. By Application
17.4.4. By End User
17.5. Market trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis and Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Ingredient
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Ingredient
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Ingredient
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Ingredient
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis By Region
18.4.1. By Country
18.4.2. By Ingredient
18.4.3. By Application
18.4.4. By End User
18.5. Market trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis and Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Ingredient
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Ingredient
18.8.2.2.2. By Application
18.8.2.2.3. By End User
19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. Northern Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Ingredient
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis By Region
19.4.1. By Country
19.4.2. By Ingredient
19.4.3. By Application
19.4.4. By End User
19.5. Market trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis and Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Ingredient
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. Türkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Ingredient
19.8.2.2.2. By Application
19.8.2.2.3. By End User
19.8.3. South Africa Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Ingredient
19.8.3.2.2. By Application
19.8.3.2.3. By End User
19.8.4. Northern Africa Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Ingredient
19.8.4.2.2. By Application
19.8.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Concentration
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Laborie
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Key Financials
21.2.1.4. Sales Footprint
21.2.1.5. SWOT Analysis
21.2.1.6. Strategy Overview
21.2.1.6.1. Marketing Strategies
21.2.1.6.2. Product Strategies
21.2.1.6.3. Channel Strategies
21.2.2. STERIS
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Key Financials
21.2.2.4. Sales Footprint
21.2.2.5. SWOT Analysis
21.2.2.6. Strategy Overview
21.2.2.6.1. Marketing Strategies
21.2.2.6.2. Product Strategies
21.2.2.6.3. Channel Strategies
21.2.3. Olympus America
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Key Financials
21.2.3.4. Sales Footprint
21.2.3.5. SWOT Analysis
21.2.3.6. Strategy Overview
21.2.3.6.1. Marketing Strategies
21.2.3.6.2. Product Strategies
21.2.3.6.3. Channel Strategies
21.2.4. Medtronic
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Key Financials
21.2.4.4. Sales Footprint
21.2.4.5. SWOT Analysis
21.2.4.6. Strategy Overview
21.2.4.6.1. Marketing Strategies
21.2.4.6.2. Product Strategies
21.2.4.6.3. Channel Strategies
21.2.5. Boston Scientific Corporation
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Key Financials
21.2.5.4. Sales Footprint
21.2.5.5. SWOT Analysis
21.2.5.6. Strategy Overview
21.2.5.6.1. Marketing Strategies
21.2.5.6.2. Product Strategies
21.2.5.6.3. Channel Strategies
21.2.6. Omnimed Ltd™
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Key Financials
21.2.6.4. Sales Footprint
21.2.6.5. SWOT Analysis
21.2.6.6. Strategy Overview
21.2.6.6.1. Marketing Strategies
21.2.6.6.2. Product Strategies
21.2.6.6.3. Channel Strategies
21.2.7. COSMO PHARMACEUTICALS
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Key Financials
21.2.7.4. Sales Footprint
21.2.7.5. SWOT Analysis
21.2.7.6. Strategy Overview
21.2.7.6.1. Marketing Strategies
21.2.7.6.2. Product Strategies
21.2.7.6.3. Channel Strategies
21.2.8. Micro-Tech Endoscopy
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Key Financials
21.2.8.4. Sales Footprint
21.2.8.5. SWOT Analysis
21.2.8.6. Strategy Overview
21.2.8.6.1. Marketing Strategies
21.2.8.6.2. Product Strategies
21.2.8.6.3. Channel Strategies
21.2.9. Ovesco Endoscopy AG
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Key Financials
21.2.9.4. Sales Footprint
21.2.9.5. SWOT Analysis
21.2.9.6. Strategy Overview
21.2.9.6.1. Marketing Strategies
21.2.9.6.2. Product Strategies
21.2.9.6.3. Channel Strategies
22. Assumptions and Acronyms Used
23. Research Methodology
Healthcare
February 2023
REP-GB-16670
288 pages
Explore Healthcare Insights
View Reports
Submucosal Lifting Agent Market
